Literature DB >> 3490466

Characterization of beta-lactamases in clinical isolates of Bacteroides.

A Eley, D Greenwood.   

Abstract

A total of 78 strains of Bacteroides was freshly isolated from clinical specimens; 60 of the strains were identified as B. fragilis and 16 as B. thetaiotaomicron. Overall, imipenem and the combination of benzylpenicillin and clavulanic acid were found to be considerably more active than cefoxitin or latamoxef (moxalactam) against these strains. Nearly all the strains exhibited weak beta-lactamase activity and 13 were judged to produce elevated levels of enzyme. These 13 strains fell into three groups: four strains that produced enzymes of low specific activity which were very susceptible to beta-lactamase inhibitors; three strains that produced enzymes of intermediate specific activity which hydrolysed cefoxitin and latamoxef at a variable rate; two of these enzymes rapidly inactivated imipenem and were insusceptible to beta-lactamase inhibitors; six strains that produced enzymes of high specific activity which were susceptible to beta-lactamase inhibitors; these strains did not inactivate beta-lactamase-stable beta-lactam antibiotics, but two of the strains nonetheless exhibited reduced susceptibility to latamoxef and imipenem.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3490466     DOI: 10.1093/jac/18.3.325

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

1.  National Committee for Clinical Laboratory Standards agar dilution susceptibility testing of anaerobic gram-negative bacteria.

Authors:  W J Brown
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

2.  Characterization of beta-lactamases from non-Bacteroides fragilis group Bacteroides spp. belonging to seven species and their role in beta-lactam resistance.

Authors:  P C Appelbaum; A Philippon; M R Jacobs; S K Spangler; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

Review 3.  Beta-lactamases in clinical isolates. Spectrum implications of sulbactam/ampicillin.

Authors:  J F Acar; L Gutmann; M D Kitzis
Journal:  Drugs       Date:  1988       Impact factor: 9.546

4.  Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins.

Authors:  Y Matsumoto; F Ikeda; T Kamimura; Y Yokota; Y Mine
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

5.  Oligonucleotide probes for detection of cephalosporinases among Bacteroides strains.

Authors:  P Mastrantonio; R Cardines; P Spigaglia
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

6.  Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989.

Authors:  C Betriu; C Cabronero; M Gomez; J J Picazo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

7.  Cloning and characterization of the endogenous cephalosporinase gene, cepA, from Bacteroides fragilis reveals a new subgroup of Ambler class A beta-lactamases.

Authors:  M B Rogers; A C Parker; C J Smith
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

8.  Insertional activation of cepA leads to high-level beta-lactamase expression in Bacteroides fragilis clinical isolates.

Authors:  M B Rogers; T K Bennett; C M Payne; C J Smith
Journal:  J Bacteriol       Date:  1994-07       Impact factor: 3.490

9.  Purification and characterization of a new beta-lactamase from Bacteroides uniformis.

Authors:  M Hedberg; L Lindqvist; T Bergman; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.